Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques-Reference-Cited by-同舟云学术

Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques

Published:2020-05-12 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Winchell Caylin G.,Mishra Bibhuti B.,Phuah Jia Yao,Saqib Mohd,Nelson Samantha J.,Maiello Pauline,Causgrove Chelsea M.,Ameel Cassaundra L.,Stein Brianne,Borish H. Jacob,White Alexander G.,Klein Edwin C.,Zimmerman Matthew D.,Dartois Véronique,Lin Philana Ling,Sassetti Christopher M.,Flynn JoAnne L.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Global Tuberculosis Report 2018,2018

2. Pulmonary impairment after tuberculosis;Pasipanodya;Chest,2007

3. Host-directed therapies for tuberculosis;Tobin;Cold Spring Harb Perspect Med,2015

4. Host-directed therapies to combat tuberculosis and associated non-communicable diseases;Baindara;Microb Pathog.,2019

5. IL-1 receptor-mediated signal is an essential component of myd88-dependent innate response to mycobacterium tuberculosis infection;Fremond;J Immunol.,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual neutrophil subsets exacerbate or suppress inflammation in tuberculosis via IL-1β or PD-L1;Life Science Alliance;2024-05-21

2. Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosis;International Immunopharmacology;2024-05

3. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus;Frontiers in Immunology;2024-01-08

4. Neutrophil subsets play dual roles in tuberculosis by producing inflammasome dependent-IL-1β or suppressing T-cells via PD-L1;2023-11-17

5. Tuberculosis: Experimental Models, Innovations, and Challenges;Recent Advances in Pharmaceutical Innovation and Research;2023